Natasha Weeks
Recent Posts
2 min read
Checking the Pulse of the Foot & Ankle Market
SmartTRAK takes a look at recent trends impacting the Foot & Ankle market.
As the first half of 2024 closes, SmartTRAK has observed a continued investment in the hallux valgus space. New implants and innovative instrumentation for hallux valgus procedures continue to push this segment to the forefront of the elective foot and ankle fixation space. While hallux valgus is front of mind for fixation, arthroplasty is also making waves as SmartTRAK continues to monitor toe replacement and advancements in ankle replacement.
As companies close out Q2 earnings, SmartTRAKcoverage has indicated slightly mixed results in the Extremities space. In this downloadable article, SmartTRAK examines recent trends impacting the Foot and Ankle market. including what's happening with hallux valgus procedures, which shows no signs of slowing down, and puts a spotlight on arthroplasty in the Foot & Ankle segment
Click the button below to download and read the complete "Checking the Pulse of the Foot & Ankle Market" article by Natasha Weeks, SmartTRAK Managing Editor/Sr. Analyst Trauma & Extremities.
2 min read
Healthy Growth: Q123 Trauma Market Recap
Strong returns in IM Nailing and a flurry of activity in the Pediatric space results in a healthy Q123 for the Trauma Market
- Complete Q123 Trauma Market Overview
- SmartTRAK's Expert Market Analysis and Insights
- All Trauma Companies' News, Revenues, Data, Charts and Market Shares
- IM Nailing Closes the Quarter on High with Solid Returns
- New Regulatory Clearances Propel the Pediatric Trauma Segment:
- OrthoPediatrics
- NuVasive Specialized Orthopedics, Inc.
- Wishbone Medical
- Q123 Trauma Regulatory Highlights
During Q1, the Pediatric Trauma segment experienced a notable surge in regulatory clearances, indicating forthcoming product launches aimed at bolstering the segment's growth. These approvals signal ...
Read the entire Q123 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*
*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. 
2 min read
New Products Propel Growth: Q422 Trauma Market Recap
Among the many topics covered in detail in our comprehensive Q422 Trauma Market Recap* are:
- Complete Q422 Trauma Market Overview and Highlights
- SmartTRAK's Expert Market Analysis and Insights
- All Company News, Revenues, Data, Charts and Shares
- Plates & Screws and IM Nails Propel Growth for the Quarter
- Globus Continues to Make Strides in Trauma Filling Out Product Portfolio
- Q422 Trauma Market Regulatory Highlights
The number one trauma player, DePuy Synthes* (46.6% Q4 US Trauma market share) attributed Q422 and full-year 2022 growth to market recovery along with market adoption of new introductions such as ...
Read the entire Q422 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*
*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
2 min read
New Products and Easier Comps Drive US Growth: Q322 Trauma Market Recap
Despite declining OUS results, the US Trauma Market experienced healthy growth attributed to adoption of new products.
While OUS results declined in Q322 due to foreign currency headwinds and China’s value-based pricing, the US drove the overall market through product penetration and easier comps due to the Q321 COVID waves that impacted procedural volumes last year. Companies posted healthy US growth, attributing new products for driving growth, with plans for additional launches in Q4 and 2023.Among the many topics covered in detail in our comprehensive Q322 Trauma Market Recap* are:
10 min read
What's New in Trauma and Extremities?
In the market for Trauma & Extremities, companies continue to innovate with new product introductions as well as a value-based care approach that promotes supporting clinical evidence for new and existing products showing their benefits to the patient and the hospital. Manufacturers are investing in solutions beyond implants to differentiate themselves and gain share in the Trauma & Extremities markets. SmartTRAK has observed a variety of strategies and solutions in the fast-paced hallux valgus segment as well as investment in deformity correction and periprosthetic solutions. The following is a sample of SmartTRAK's recent Trauma & Extremities news and developments from around the world, compiled, curated and posted in real-time by the expert analysts at SmartTRAK.
We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more. Our users think it's the perfect way to start their day.
New Products:
- CAPTIVATE Cannulated Screw System* - Globus*
Globus announced the launch of the CAPTIVATE Headed Cannulated Screw System in diameters 2.5/3.0 mm, 3.5/4.0 mm, 4.5/5.5 mm. SmartTRAK reviewed the products at OTA with Globus as the Company fills out its Trauma & Extremities portfolio. LinkedIn
1 min read
Trends and Advancements in Foot & Ankle: AOFAS 2022
SmartTRAK highlights new products and Company strategies to penetrate the Foot & Ankle space at AOFAS 2022
SmartTRAK identified several key themes and takeaways from the American Orthopaedic Foot & Ankle Society (AOFAS) 2022 meeting held recently in Quebec City, Canada. Manufacturers showcased product introductions with a continued focus on hallux valgus solutions and are investing in solutions beyond implants to differentiate themselves and gain share in the US Foot & Ankle Market.
Among the many topics covered in detail in the complete article, which can be downloaded here, are:
- Small, Niche Players Attempt to Gain Share
- Globus Fills Out Trauma and Extremities Product Portfolios
- Enovis Showcases New Products and Gains Traction in F&A Space
- Direct-To-Consumer Marketing Drives Growth in Hallux Valgus Market
- Treace Medical Outpaces Others
- Medartis Showcases New Products
- JNJ/DePuy/Synthes' Acquisition
- Paragon28 Focuses on the MIS Segment
To download the complete "AOFAS 2022: Trends and Advancements in Foot & Ankle" article by SmartTRAK's Natasha Weeks, Sr. Analyst, Trauma & Extremities, just click the button below.
2 min read
Trends and Advancements in Trauma: OTA 2022
SmartTRAK highlights the latest trends and innovations at OTA 2022, with a focus on deformity correction and limb lengthening.
Stepping Outside of Internal Fixation
In the market for ring fixation devices, companies have been innovating beyond static frames and are developing dynamic, computer-assisted hexapod frames to treat bone fractures and deformity corrections. One of the challenges with hexapod frames is that they require manual strut adjustments, a process that is prone to patient and clinician error and can require up to 20 manual adjustments per day—a definite burden on the patient and caregiver ...
2 min read
New Products Will Drive Growth: Q222 Trauma Market Recap
Quarterly growth stalled due to weather, supply chain and staffing, but the promise of new product introductions in H2 will return healthy growth to the Trauma Market.
The Q222 Trauma Market was impacted by several conditions that contributed to decelerating growth, such as a reduced demand for trauma-related devices, supply chain challenges and facility staffing hurdles. The WW Trauma Market growth slowed sequentially in Q2, down compared to Q122’s growth. The US Trauma Market fared a bit better than WW results, but also experienced a sequential slump compared to Q122. For the first half of 2022, the US Trauma Market was up +3.5% YTD growth compared to H121.
Among the many topics covered in detail in our comprehensive Q222 Trauma Market Recap* are:
- Complete Q222 Trauma Overview and Highlights
- SmartTRAK's Expert Analysis and Insights
- All Company News including Revenues, Data, Charts and Shares
- Mergers & Acquisitions
- Q222 Trauma Regulatory Highlights
2 min read
Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap
Despite mixed results from Trauma players, the segment experienced healthy growth as mergers and acquisitions were plentiful and regulatory clearances show promise of future new product introductions.
